Life Technologies Corporation
) announced that it intends to enhance production of its genetic
analysis products by investing $18 million for the expansion of
its Pleasanton, Calif. facility. Life Technologies is planning to
implement Current Good Manufacturing Practice (cGMP) capabilities
at this facility to broaden its portfolio of molecular diagnostic
products in order to meet increased demand. The project is
expected to take effect in the second quarter of 2013.
As of now, TaqMan assays, GeneArt and Ion AmpliSeq product
lines are manufactured at the Pleasanton facility. In the first
phase of the project, the company will convert 10,000 square feet
of the facility to manufacture molecular probes and primers in
compliance with the cGMP standards. Subsequently, the company
plans to expand the facility by 30,000 square feet over a span of
three years. The expanded facility will be used to produce
regulatory-complaint material for qPCR workflows.
The products manufactured at the cGMP-certified facilities
have to maintain a high standard of quality and control. As of
now, LIFE manufactures a number of products including assays,
various reagents, sera, cell culture media and instruments under
the cGMP standards and ISO 9001/1348 certification, in nine
Currently, LIFE carries a Zacks Rank #3 (Hold). Over the last
two years, LIFE has been focusing on creating an optimal
portfolio of products through innovation and acquisitions. We are
also encouraged by LIFE's strategy to strengthen its presence in
the high growth markets such as Latin America, the Middle East,
China and India. Over the next few years, LIFE's focus on
developing industry-leading franchises in high-growth technology
areas, applied markets and emerging geographies will be the key
drivers of long-term growth.
Other medical product stocks are
). While NuVasive carries a Zacks Rank #1 (Strong Buy), DynaVox
Inc. and Conceptus, Inc. carry a Zacks Rank #2 (Buy).
CONCEPTUS INC (CPTS): Free Stock Analysis
DYNAVOX INC-A (DVOX): Free Stock Analysis
LIFE TECHNOLOGS (LIFE): Free Stock Analysis
NUVASIVE INC (NUVA): Free Stock Analysis
To read this article on Zacks.com click here.